Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-29 Sale |
2022-08-31 7:03 pm |
SANGAMO THERAPEUTICS INC | SGMO | BIOGEN INC. Biogen MA Inc. 10% Owner |
500,000 | $5.3145 | $2,657,240 | 23,652,466 (Indirect) |
View |
| 2022-06-03 Purchase |
2022-06-06 4:41 pm |
SANGAMO THERAPEUTICS INC | SGMO | Markels John Director |
6,784 | $3.6894 | $25,029 | 32,484 (Direct) |
View |
| 2022-06-01 Purchase |
2022-06-03 4:18 pm |
SANGAMO THERAPEUTICS INC | SGMO | PARKER H STEWART Director |
5,000 | $3.5992 | $17,996 | 48,700 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-25 Tax Withholding |
2023-03-28 5:04 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, Chief Financial Officer |
345 | $1.66 | 133,380 (Direct) |
View |
| 2023-02-25 Tax Withholding |
2023-03-06 5:10 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, Gen. Counsel & Secretary |
5,128 | $2.66 | 330,089 (Direct) |
View |
| 2023-02-24 Option Award |
2023-03-06 5:10 pm |
N/A 2033-02-23 |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, Gen. Counsel & Secretary |
242,250 | $0 | 330,089 (Direct) |
View |
| 2023-02-25 Tax Withholding |
2023-03-06 5:09 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Ramelmeier Rolf Andrew EVP, Technical Operations |
15,618 | $2.66 | 383,217 (Direct) |
View |
| 2023-02-24 Option Award |
2023-03-06 5:09 pm |
N/A 2033-02-23 |
SANGAMO THERAPEUTICS INC | SGMO | Ramelmeier Rolf Andrew EVP, Technical Operations |
255,000 | $0 | 383,217 (Direct) |
View |
| 2023-02-25 Tax Withholding |
2023-03-06 5:09 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Operating Officer |
9,745 | $2.66 | 487,274 (Direct) |
View |
| 2023-02-24 Option Award |
2023-03-06 5:09 pm |
N/A 2033-02-23 |
SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Operating Officer |
318,750 | $0 | 487,274 (Direct) |
View |
| 2023-02-25 Tax Withholding |
2023-03-06 5:08 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-Chief Development Officer |
9,834 | $2.66 | 387,933 (Direct) |
View |
| 2023-02-24 Option Award |
2023-03-06 5:08 pm |
N/A 2033-02-23 |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-Chief Development Officer |
302,813 | $0 | 387,933 (Direct) |
View |
| 2023-02-25 Tax Withholding |
2023-03-06 5:07 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Fontenot Jason D. SVP, Chief Scientific Officer |
6,559 | $2.66 | 338,858 (Direct) |
View |
| 2023-02-24 Option Award |
2023-03-06 5:07 pm |
N/A 2033-02-23 |
SANGAMO THERAPEUTICS INC | SGMO | Fontenot Jason D. SVP, Chief Scientific Officer |
242,250 | $0 | 338,858 (Direct) |
View |
| 2023-02-25 Tax Withholding |
2023-03-06 5:07 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, Chief Financial Officer |
7,030 | $2.66 | 383,100 (Direct) |
View |
| 2023-02-24 Option Award |
2023-03-06 5:07 pm |
N/A 2033-02-23 |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, Chief Financial Officer |
302,813 | $0 | 383,100 (Direct) |
View |
| 2023-02-25 Tax Withholding |
2023-03-06 5:06 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy President, CEO and Director |
54,767 | $2.66 | 1,357,759 (Direct) |
View |
| 2023-02-24 Option Award |
2023-03-06 5:06 pm |
N/A 2033-02-23 |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy President, CEO and Director |
891,350 | $0 | 1,357,759 (Direct) |
View |
| 2022-06-11 Tax Withholding(A) |
2023-02-06 6:28 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, Chief Financial Officer |
864 | $3.76 | 86,595 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-19 5:02 pm |
N/A 2032-12-14 |
SANGAMO THERAPEUTICS INC | SGMO | Beers Courtney Director |
56,250 | $0 | 56,250 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-19 4:45 pm |
N/A 2032-12-14 |
SANGAMO THERAPEUTICS INC | SGMO | Horn Margaret A Director |
56,250 | $0 | 56,250 (Direct) |
View |
Ownership |
2022-12-19 4:42 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Horn Margaret A Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2022-12-19 4:27 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Beers Courtney Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2022-09-19 7:24 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-Chief Development Officer |
0 | $0 | 419,581 (Direct) |
View |
| 2022-08-13 Tax Withholding |
2022-08-16 5:58 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, Gen. Counsel & Secretary |
864 | $6.33 | 92,966 (Direct) |
View |
| 2022-06-25 Tax Withholding |
2022-06-28 5:25 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Operating Officer |
11,525 | $4.31 | 175,816 (Direct) |
View |
| 2022-06-11 Tax Withholding |
2022-06-14 4:37 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha Vice President, Finance |
842 | $3.76 | 86,617 (Direct) |
View |
| 2022-04-29 Tax Withholding |
2022-05-03 5:09 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, Gen. Counsel & Secretary |
140 | $4.15 | 90,709 (Direct) |
View |
| 2022-04-25 Tax Withholding |
2022-04-27 5:09 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Fontenot Jason D. SVP, Chief Scientific Officer |
826 | $4.83 | 103,167 (Direct) |
View |
| 2022-04-25 Tax Withholding |
2022-04-27 5:08 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha Vice President, Finance |
662 | $4.83 | 86,772 (Direct) |
View |
| 2022-04-24 Tax Withholding |
2022-04-26 5:37 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, Gen. Counsel & Secretary |
3,976 | $4.7 | 90,849 (Direct) |
View |
| 2022-03-25 Tax Withholding |
2022-03-29 4:41 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha Vice President, Finance |
345 | $5.75 | 87,434 (Direct) |
View |
| 2022-02-25 Option Award |
2022-03-01 5:21 pm |
N/A 2032-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, Gen. Counsel & Secretary |
151,700 | $0 | 205,525 (Direct) |
View |
| 2022-02-25 Tax Withholding |
2022-03-01 5:21 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, Gen. Counsel & Secretary |
1,566 | $5.9 | 205,525 (Direct) |
View |
| 2022-02-25 Option Award |
2022-03-01 5:20 pm |
N/A 2032-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Schott Robert J. SVP, Head of Development |
151,700 | $0 | 186,237 (Direct) |
View |
| 2022-02-25 Option Award |
2022-03-01 5:19 pm |
N/A 2032-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Ramelmeier Rolf Andrew EVP, Technical Operations |
199,800 | $0 | 288,229 (Direct) |
View |
| 2022-02-25 Tax Withholding |
2022-03-01 5:19 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Ramelmeier Rolf Andrew EVP, Technical Operations |
12,388 | $5.9 | 288,229 (Direct) |
View |
| 2022-02-25 Option Award |
2022-03-01 5:18 pm |
N/A 2032-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Fontenot Jason D. SVP, Chief Scientific Officer |
166,870 | $0 | 225,763 (Direct) |
View |
| 2022-02-25 Tax Withholding |
2022-03-01 5:18 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Fontenot Jason D. SVP, Chief Scientific Officer |
6,248 | $5.9 | 225,763 (Direct) |
View |
| 2022-02-25 Option Award |
2022-03-01 5:18 pm |
N/A 2032-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha Vice President, Finance |
151,700 | $0 | 198,479 (Direct) |
View |
| 2022-02-25 Tax Withholding |
2022-03-01 5:18 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha Vice President, Finance |
3,474 | $5.9 | 198,479 (Direct) |
View |
| 2022-02-25 Option Award |
2022-03-01 5:17 pm |
N/A 2032-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Operating Officer |
219,780 | $0 | 345,364 (Direct) |
View |
| 2022-02-25 Tax Withholding |
2022-03-01 5:17 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Operating Officer |
4,610 | $5.9 | 345,364 (Direct) |
View |
| 2022-02-25 Option Award |
2022-03-01 5:16 pm |
N/A 2032-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy President, CEO and Director |
828,800 | $0 | 1,125,976 (Direct) |
View |
| 2022-02-25 Tax Withholding |
2022-03-01 5:16 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy President, CEO and Director |
49,890 | $5.9 | 1,125,976 (Direct) |
View |
| 2022-02-25 Option Award |
2022-03-01 5:15 pm |
N/A 2032-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Zakrzewski Joseph S Director |
37,500 | $0 | 85,700 (Direct) |
View |
| 2022-02-25 Option Award |
2022-03-01 5:14 pm |
N/A 2032-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Smith Karen L. Director |
37,500 | $0 | 63,200 (Direct) |
View |
| 2022-02-25 Option Award |
2022-03-01 5:13 pm |
N/A 2032-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Ramasastry Saira Director |
37,500 | $0 | 60,700 (Direct) |
View |
| 2022-02-25 Option Award |
2022-03-01 5:12 pm |
N/A 2032-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | PARKER H STEWART Director |
37,500 | $0 | 68,700 (Direct) |
View |
| 2022-02-25 Option Award |
2022-03-01 5:11 pm |
N/A 2032-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Meyers James R Director |
37,500 | $0 | 60,700 (Direct) |
View |
| 2022-02-25 Option Award |
2022-03-01 5:10 pm |
N/A 2032-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Markels John Director |
37,500 | $0 | 50,700 (Direct) |
View |
| 2022-02-25 Option Award |
2022-03-01 5:09 pm |
N/A 2032-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Hillan Kenneth J. Director |
37,500 | $0 | 60,700 (Direct) |
View |
| 2022-02-25 Option Award |
2022-03-01 5:07 pm |
N/A 2032-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Carey Robert Director |
37,500 | $0 | 60,700 (Direct) |
View |